Microbio, Translational Research Institute (TRI), 37 Kent Street, Brisbane (2026)

16/03/2026

We are delighted to welcome Ana Illera López to Microbio as our new Field Application Specialist!

Based in Spain, Ana brings a strong combination of scientific expertise, hands-on technical experience, and international perspective that will support customers and partners across Europe as they adopt InfectID™-BSI.

Ana holds a PhD in Human Genetics and an MRes in Biomedical Sciences and Translational Medicine from the University of Liverpool, along with a BSc in Genetics and Cell Biology. Her career has taken her across Spain, the United Kingdom, and Ireland, giving her valuable experience working across different scientific and clinical environments.

Ana's technical expertise, communication skills, and customer-focused approach will be invaluable as she supports customers and distributors implementing InfectID™-BSI, Microbio's rapid qPCR-based diagnostic designed to enable faster pathogen identification in sepsis and support more targeted treatment decisions.

Welcome to the team, Ana!

22/12/2025

Early pathogen identification plays a critical role in antimicrobial stewardship, especially in patients with suspected sepsis.

When clinicians have faster insight into the likely cause of infection, they can move beyond prolonged empirical therapy and make more informed treatment decisions. This supports antimicrobial stewardship efforts and helps protect the effectiveness of existing therapies.

Read our latest blog post to explore why timing matters more than ever.
👉 https://hubs.li/Q03YTq3x0

09/12/2025

Each year, sepsis affects an estimated 49 million people worldwide including over 20 million children under 5 and nearly 5 million older children and teens.

This life-threatening condition can escalate quickly, but early detection saves lives. At Microbio, we’re committed to developing rapid, accurate diagnostics to help clinicians detect infections faster and act sooner.

Because every life counts.

01/12/2025

Today, on World AIDS Day, we acknowledge the ongoing global effort to address HIV and related infectious diseases. Effective diagnostics remain central to that effort. When clinicians have access to fast, accurate results, they can make better decisions for their patients and strengthen public health responses at scale.

At Microbio, our work focuses on providing tools that support early detection of infectious agents. Accessible diagnostics are a key part of improving outcomes for communities everywhere.

Address

Translational Research Institute (TRI), 37 Kent Street
Brisbane, QLD
4102

Website

https://microbio.com.au/

Alerts

Be the first to know and let us send you an email when Microbio posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Microbio